Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00183495 · ClinicalTrials.gov registry record
Understanding Treatment Adherence Among Individuals With Bipolar Disorder
A clinical trial, sponsored by Case Western Reserve University.
- Completed
- Registry status
- 140
- Enrollment target
NCT00183495: Completed study, sponsored by Case Western Reserve University.
NCT00183495 is a clinical trial that has completed, run by Case Western Reserve University. The registered enrollment target is 140 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00183495 has completed, sponsored by Case Western Reserve University.
- COMPLETED
- Registry status
- 140 participants
- Enrollment target
Study Summary
This study will examine how various factors, such as psychiatric symptoms, gender, social support, substance use, and attitudes toward medication, affect treatment adherence in individuals with bipolar disorder.
Primary Outcome
The AMSQ is a 19-item scale which is a modification of the Lithium Attitudes Questionnaire (LAQ) that evaluates an individual's attitude toward mood-stabilizing medication. The questions are in a yes/no format. The AMSQ has 7 subscales that represent key attitudinal domains with respect to adherence, as follows: 1. opposition to prophylaxis, 2. denial of therapeutic effectiveness, 3. fear of adverse effects, 4. difficulty with medication routines, 5. denial of illness severity, 6. negative attit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2004-03 |
| Est. Completion | 2007-08 |
What the finished NCT00183495 record still lists
NCT00183495 is an observational study that tracks outcomes without assigning an intervention. The registered 140 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00183495 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00183495 about?
NCT00183495 is a clinical study titled "Understanding Treatment Adherence Among Individuals With Bipolar Disorder". This study will examine how various factors, such as psychiatric symptoms, gender, social support, substance use, and attitudes toward medication, affect treatment adherence in individuals with bipolar disorder.
What is the current status of trial NCT00183495?
This trial is currently completed. The enrollment target is 140 participants. The study started on 2004-03. Estimated completion is 2007-08.
Who is sponsoring clinical trial NCT00183495?
This trial is sponsored by Case Western Reserve University, which has 141 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01419561 · 140 participants · Phase 2
Natural History Study of the KSHV Inflammatory Cytokine Syndrome (KICS)
- NCT01624805 · 140 participants · Phase 2
Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome
- NCT02369770 · 140 participants · NA
Sensory-Motor Rehabilitation Post Stroke
- NCT02455193 · 140 participants · NA
Neuronal Effects of Exercise in Schizophrenia
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia